IQVIA Holdings Inc. (IQV)
| Market Cap | 43.69B |
| Revenue (ttm) | 15.16B |
| Net Income (ttm) | 1.42B |
| Shares Out | 182.30M |
| EPS (ttm) | 7.69 |
| PE Ratio | 31.17 |
| Forward PE | 20.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,195,031 |
| Open | 235.58 |
| Previous Close | 232.29 |
| Day's Range | 233.99 - 239.95 |
| 52-Week Range | 167.42 - 261.73 |
| Beta | 1.50 |
| Analysts | Strong Buy |
| Price Target | 263.56 (+9.97%) |
| Earnings Date | Jul 22, 2024 |
About IQV
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ge... [Read more]
Financial Performance
In 2023, IQVIA Holdings's revenue was $14.98 billion, an increase of 3.98% compared to the previous year's $14.41 billion. Earnings were $1.36 billion, an increase of 24.47%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for IQV stock is "Strong Buy." The 12-month stock price forecast is $263.56, which is an increase of 9.97% from the latest price.
News
These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings
IQVIA Holdings Inc IQV posted better-than-expected second-quarter earnings on Monday.
IQVIA Stock Pops After It Beats Q2 Earnings Estimates
IQVIA Holdings (IQV) beat second-quarter earnings expectations and raised its full-year outlook on Monday, sending shares higher.
IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings
IQVIA Holdings Inc IQV reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.
IQVIA raises annual profit forecast on improving demand for analytics services
Contract research firm IQVIA Holdings raised its forecast for full-year profit on Monday, banking on strength in demand for its healthcare data and analytics services.
IQVIA Reports Second-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the li...
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulat...
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQ...
IQVIA's SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences industry,...
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for th...
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--As cancer incidence continues to rise, it's being met by wider use of innovative therapies and a robust pipeline of new drugs, according to a new report ...
Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings
The Investment Committee give you their top stocks to watch for the second half.
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Overall spending in the U.S. market for medicines grew by 2.5% and reached $435Bn in 2023. Excluding the contribution from COVID-19 vaccines and therapeu...
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank...
IQVIA trims full-year revenue forecast on stronger dollar
Contract research firm IQVIA Holdings lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched metric, sending shares down...
IQVIA Reports First-Quarter 2024 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the li...
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strate...
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQV...
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce...
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bar...
IQVIA Publishes its 2023 Environmental, Social and Governance Report
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report. The annual report provides a detailed account of the organiz...
IQVIA CFO Ron Bruehlman to Speak at Citi's Unplugged Medtech and Life Sciences Access Day on February 29, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi's ...
IQVIA quarterly results beat estimates on strong demand for research services
IQVIA Holdings beat Wall Street estimates for fourth-quarter sales and profit on Wednesday, on the back of strong demand for its drug research and development services.
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the li...
IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, ha...
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14...